218 related articles for article (PubMed ID: 35178875)
1. Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non-small cell lung cancer (NSCLC) via the PI3K/AKT pathway.
Zhu W; Shi L; Gong Y; Zhuo L; Wang S; Chen S; Zhang B; Ke B
Thorac Cancer; 2022 Apr; 13(7):1027-1039. PubMed ID: 35178875
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
3. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
[TBL] [Abstract][Full Text] [Related]
5. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
6. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.
Liu XX; Xiong HP; Huang JS; Qi K; Xu JJ
Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):895-902. PubMed ID: 28477368
[TBL] [Abstract][Full Text] [Related]
7. LAGE3 promotes cell metastasis and stemness in non-small cell lung cancer companied with AKT/PI3K signaling pathway activation.
Zhang H; Jian J; Chen H; Zhu X; Xie J; Xu X
Pathol Res Pract; 2023 Aug; 248():154700. PubMed ID: 37473499
[TBL] [Abstract][Full Text] [Related]
8. CDKL3 Promotes Non-small Cell Lung Cancer by Suppressing Autophagy Via Activation of PI3K/Akt/mTOR Pathway.
Li R; Chai L; Lei L; Guo R; Wen X
Mol Biotechnol; 2023 Sep; 65(9):1421-1431. PubMed ID: 36630073
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/Akt pathway.
Yang F; Zheng Y; Luo Q; Zhang S; Yang S; Chen X
BMC Cancer; 2024 Apr; 24(1):408. PubMed ID: 38566039
[TBL] [Abstract][Full Text] [Related]
11. Circ_0017639 facilitates proliferative, migratory, and invasive potential of non-small cell lung cancer (NSCLC) cells via PI3K/AKT signaling pathway.
Zhang HB; Qiu XM; Zhang YC; Huang TT; Zuo ZJ; Zhang T
Bioengineered; 2022 Jan; 13(1):1590-1601. PubMed ID: 35000535
[TBL] [Abstract][Full Text] [Related]
12. Kinetochore scaffold 1 downregulation suppressed the development of non-small cell lung cancer by inactivating the phosphatidylinositol 3 kinase/protein kinase B (AKT)/nuclear factor-kappa B pathway.
Wu L; Zhang G; Zhu Q; Huang Y
J Physiol Pharmacol; 2024 Feb; 75(1):. PubMed ID: 38583438
[TBL] [Abstract][Full Text] [Related]
13. Triptolide restrains the growth, invasion, stemness, and glycolysis of non-small cell lung cancer cells by PFKFB2-mediated PI3K/AKT pathway.
Ren J; Zhao S; Lai J
Chem Biol Drug Des; 2024 Jan; 103(1):e14450. PubMed ID: 38230789
[TBL] [Abstract][Full Text] [Related]
14. PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway.
Wang S; Cheng Z; Cui Y; Xu S; Luan Q; Jing S; Du B; Li X; Li Y
J Transl Med; 2023 Nov; 21(1):819. PubMed ID: 37974250
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-122-5p promotes the development of non-small cell lung cancer via downregulating p53 and activating PI3K-AKT pathway.
Fan X; Wu X
J BUON; 2019; 24(1):273-279. PubMed ID: 30941980
[TBL] [Abstract][Full Text] [Related]
16. PCGF3 promotes the proliferation and migration of non-small cell lung cancer cells via the PI3K/AKT signaling pathway.
Hu Y; Cheng Y; Jiang X; Zhang Y; Wang H; Ren H; Xu Y; Jiang J; Wang Q; Su H; Zhang B; Qiu X
Exp Cell Res; 2021 Mar; 400(2):112496. PubMed ID: 33485844
[TBL] [Abstract][Full Text] [Related]
17. Elevation of LEM Domain Containing 1 Predicts Poor Prognosis of NSCLC Patients and Triggers Malignant Stemness and Invasion of NSCLC Cells by Stimulating PI3K/AKT Pathway.
Li L; Zhang P
Curr Mol Med; 2024; 24(3):366-378. PubMed ID: 36967459
[TBL] [Abstract][Full Text] [Related]
18. RHBDD1 silencing inhibited cell growth and invasion of non-small cell lung cancer by mediating ZEB1/PI3K/AKT signaling pathway.
Xu Z; Wang R; Li X; Yang L; Peng H; Wang Y; Wang P
J Mol Histol; 2021 Jun; 52(3):503-510. PubMed ID: 33515112
[TBL] [Abstract][Full Text] [Related]
19. Glycogen phosphorylase B promotes cell proliferation and migration through PI3K/AKT pathway in non-small cell lung cancer.
Zhan Y; Chen R; Wang T; Shan S; Zhu H
Exp Lung Res; 2021 Apr; 47(3):111-120. PubMed ID: 33336613
[TBL] [Abstract][Full Text] [Related]
20. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
Yang WB; Zhang WP; Shi JL; Wang JW
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
